MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Purpose Melanoma represents an important public health problem, due to its high case-fatality rate. Identification of individuals at high risk would be of major interest to improve early diagnosis and ultimately survival. The aim of this study was to evaluate whether MC1R variants predicted melanoma risk independently of at-risk phenotypic characteristics. Materials and methods Data were collected within an international collaboration – the M-SKIP project. The present pooled analysis included data on 3,830 single, primary, sporadic, cutaneous melanoma cases and 2,619 controls from seven previously published case–control studies. All the studies had information on MC1R gene variants by sequencing analysis and on hair color, skin phototype, and freckles, ie, the phenotypic characteristics used to define the red hair phenotype. Results The presence of any MC1R variant was associated with melanoma risk independently of phenotypic characteristics (OR 1.60; 95% CI 1.36–1.88). Inclusion of MC1R variants in a risk prediction model increased melanoma predictive accuracy (area under the receiver-operating characteristic curve) by 0.7% over a base clinical model (P=0.002), and 24% of participants were better assessed (net reclassification index 95% CI 20%–30%). Subgroup analysis suggested a possibly stronger role of MC1R in melanoma prediction for participants without the red hair phenotype (net reclassification index: 28%) compared to paler skinned participants (15%). Conclusion The authors suggest that measuring the MC1R genotype might result in a benefit for melanoma prediction. The results could be a valid starting point to guide the development of scientific protocols assessing melanoma risk prediction tools incorporating the MC1R genotype.

[1]  J. Pearson,et al.  Mutation load in melanoma is affected by MC1R genotype , 2017, Pigment cell & melanoma research.

[2]  Rajiv Kumar,et al.  TERT promoter mutations associate with MC1R variants in melanoma patients , 2017, Pigment cell & melanoma research.

[3]  N. Bartolomeo,et al.  Detrimental effects of melanocortin‐1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors , 2016, Pigment cell & melanoma research.

[4]  S. Puig,et al.  Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project. , 2016, The Journal of investigative dermatology.

[5]  M. Weinstock,et al.  Visual Inspection and the US Preventive Services Task Force Recommendation on Skin Cancer Screening. , 2016, JAMA.

[6]  Paula R. Blasi,et al.  Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[7]  Tumaini R. Coker,et al.  Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.

[8]  Nicola D. Roberts,et al.  Germline MC1R status influences somatic mutation burden in melanoma , 2016, Nature Communications.

[9]  J. D'Orazio,et al.  Melanocortin 1 Receptor: Structure, Function, and Regulation , 2016, Front. Genet..

[10]  P. Raina,et al.  Multigene panels in prostate cancer risk assessment: a systematic review , 2015, Genetics in Medicine.

[11]  D. Whiteman,et al.  Independent validation of six melanoma risk prediction models. , 2015, The Journal of investigative dermatology.

[12]  N. Bartolomeo,et al.  Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants , 2015, Archives of Dermatological Research.

[13]  Z. Abdel‐Malek,et al.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation , 2014, Pigment cell & melanoma research.

[14]  D. Polsky,et al.  Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance , 2014, PloS one.

[15]  Jiali Han,et al.  MC1R variants increased the risk of sporadic cutaneous melanoma in darker‐pigmented Caucasians: A pooled‐analysis from the M‐SKIP project , 2014, International journal of cancer.

[16]  Bruce K Armstrong,et al.  Risk prediction models for incident primary cutaneous melanoma: a systematic review. , 2014, JAMA dermatology.

[17]  J. Barrett,et al.  MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study , 2013, BMC Cancer.

[18]  J. Ioannidis,et al.  Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study , 2013, PloS one.

[19]  Linda Valeri,et al.  Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. , 2013, Psychological methods.

[20]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[21]  B. Dréno,et al.  Validation of the Self-Assessment of Melanoma Risk Score for a melanoma-targeted screening , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  P. Queirolo,et al.  MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients , 2012, Experimental dermatology.

[23]  T. Dwyer,et al.  Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies , 2012, BMC Medical Research Methodology.

[24]  J. Fortin,et al.  Selected Melanocortin 1 Receptor Single-Nucleotide Polymorphisms Differentially Alter Multiple Signaling Pathways , 2012, Journal of Pharmacology and Experimental Therapeutics.

[25]  V. Swope,et al.  Alpha-Melanocyte–Stimulating Hormone Suppresses Oxidative Stress through a p53-Mediated Signaling Pathway in Human Melanocytes , 2012, Molecular Cancer Research.

[26]  R. Sturm,et al.  MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture. , 2012, The Journal of investigative dermatology.

[27]  D. Schadendorf,et al.  Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study , 2012, Pigment cell & melanoma research.

[28]  Peter Kraft,et al.  Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[29]  Caitlin P. McHugh,et al.  Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. , 2011, Human molecular genetics.

[30]  N. Hayward,et al.  Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burden , 2011, International journal of cancer.

[31]  John P A Ioannidis,et al.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. , 2011, Journal of the National Cancer Institute.

[32]  S. Tognazzo,et al.  Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy , 2011, Pigment cell & melanoma research.

[33]  D. English,et al.  A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact , 2011, Genetic epidemiology.

[34]  D. Clayton,et al.  The Simpson's paradox unraveled. , 2011, International journal of epidemiology.

[35]  M. Gail,et al.  Predicting the Future of Genetic Risk Prediction , 2011, Cancer Epidemiology, Biomarkers and Prevention.

[36]  Stijn Vansteelandt,et al.  Odds ratios for mediation analysis for a dichotomous outcome. , 2010, American journal of epidemiology.

[37]  David A. Hinds,et al.  Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.

[38]  D. Elder,et al.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? , 2010, Cancer.

[39]  N. Gruis,et al.  Management of Melanoma Families , 2010, Cancers.

[40]  J. Malvehy,et al.  Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.

[41]  D. Elder,et al.  MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.

[42]  D. Duffy,et al.  Red hair is the null phenotype of MC1R , 2008, Human mutation.

[43]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[44]  T. Manolio,et al.  How to Interpret a Genome-wide Association Study Topic Collections , 2022 .

[45]  D. Duffy,et al.  Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. , 2007, Human molecular genetics.

[46]  G. Barsh,et al.  Distinct Pigmentary and Melanocortin 1 Receptor–Dependent Components of Cutaneous Defense against Ultraviolet Radiation , 2006, PLoS genetics.

[47]  D. Pinkel,et al.  MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.

[48]  K. Wakamatsu,et al.  Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. , 2006, Pigment cell research.

[49]  P. Carli,et al.  Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2006, Journal of the National Cancer Institute.

[50]  J. García-Borrón,et al.  Melanocortin-1 receptor structure and functional regulation. , 2005, Pigment cell research.

[51]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[52]  Maria Teresa Landi,et al.  MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2005, Journal of the National Cancer Institute.

[53]  Andrew N Freedman,et al.  Cancer risk prediction models: a workshop on development, evaluation, and application. , 2005, Journal of the National Cancer Institute.

[54]  D. Whiteman,et al.  A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.

[55]  R. Sturm,et al.  Novel MC1R variants in Ligurian melanoma patients and controls , 2004, Human mutation.

[56]  A. Chompret,et al.  Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. , 2004, Journal of the National Cancer Institute.

[57]  T. Dwyer,et al.  Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? , 2004, American journal of epidemiology.

[58]  Wei Chen,et al.  Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. , 2003, Human molecular genetics.

[59]  J. Protheroe Communicating risk , 2003, BMJ : British Medical Journal.

[60]  N. G. Martin,et al.  Genetic Association and Cellular Function of MC1R Variant Alleles in Human Pigmentation , 2003, Annals of the New York Academy of Sciences.

[61]  F. Collins,et al.  A vision for the future of genomics research , 2003, Nature.

[62]  R. Willemze,et al.  Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.

[63]  R. Pill,et al.  Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score , 1998, BMJ.

[64]  N. Martin,et al.  Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.

[65]  R. Lucas,et al.  Validation of Brief Questionnaire Measures of Sun Exposure and Skin Pigmentation Against Detailed and Objective Measures Including Vitamin D Status , 2013, Photochemistry and photobiology.

[66]  Jochen K. Lennerz,et al.  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair / fair skin background , 2012 .

[67]  J. Hansson Familial melanoma. , 2008, The Surgical clinics of North America.

[68]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.

[69]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.